Vaginal Bromocriptine for Treatment of Adenomyosis

Status Completed

Clinical Trial Summary

Adenomyosis is a rare non-malignant disease of the uterus that causes significant symptoms including heavy menstrual bleeding and pelvic pain. The only widely accepted treatment for adenomyosis is hysterectomy. The investigators will use a dopamine agonist, bromocriptine, as a therapy based on animal models of the disease and our prior clinical research to observe any objective improvement in the extent of the disease using Magnetic Resonance Imaging (MRI)and standard measurements for other gynecologic diseases to measure symptomatology.

Clinical Trial Description

Women with adenomyosis proven with MRI will be considered for the intervention with bromocriptine. They will be reassessed at 1, 6 and 9 months. Patients will get a stipend for each visit they complete. The study will end for the enrolled subject at 9th month follow-up ;

Study Design

Related Conditions & MeSH terms

Adenomyosis

Clinical Trial Details

NCT number	NCT01821001
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 1
Start date	March 2013
Completion date	January 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04665414` - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Recruiting	`NCT04209127` - Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis	N/A
Completed	`NCT05751876` - Dienogest in Perimenopausal Women With Adenomyosis
Recruiting	`NCT01048931` - Single-port Access Laparoscopic-assisted Vaginal Hysterectomy	Phase 3
Active, not recruiting	`NCT06223464` - Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
Completed	`NCT05419414` - The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis	N/A
Recruiting	`NCT04126824` - Effect of Addition of Steroids on Duration of Analgesia	Early Phase 1
Recruiting	`NCT05152667` - Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin
Not yet recruiting	`NCT03654144` - Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis	Phase 4
Completed	`NCT02192606` - Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?	N/A
Completed	`NCT01992718` - What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography	Early Phase 1
Recruiting	`NCT02495311` - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Recruiting	`NCT03742843` - A Multi-omics Study of Adenomyosis
Recruiting	`NCT04481321` - Clinical and Molecular Study of Endometriosis and Adenomyosis
Recruiting	`NCT04894292` - The Effect of Adenomoyosis on Pregnancy Outcomes
Completed	`NCT03520439` - Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis	Phase 2/Phase 3
Recruiting	`NCT05937490` - Adenomyosis and ART	Phase 4
Recruiting	`NCT06373822` - New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Recruiting	`NCT04295109` - Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function	N/A
Recruiting	`NCT04356664` - Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis	Phase 2/Phase 3